Shahneen Sandhu

32PUBLICATIONS
343CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsMedical molecular engineering of nucleic acids and proteinsPredictive and prognostic markersTumour immunology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (32)

|Oct 01, 2026
Five-year survival with neoadjuvant therapy in melanoma: updated pooled analysis from the International Neoadjuvant Melanoma Consortium (INMC).

|Aug 11, 2026
Spatial Profiling Reveals Immune Escape Pathways and Therapeutic Vulnerabilities in Prostate Cancer Bone Metastases.

|Jul 13, 2026
An anti-PMEL antibody-drug conjugate with a Gq/11 inhibitor payload in GNAQ/GNA11-mutant melanomas: a phase 1 trial.

|Jul 02, 2026
Germline CDK12 variants in aggressive prostate cancer.

|Jun 19, 2026
Recurrent intra-tumour heterogeneity is a hallmark of metastatic prostate cancer.

|Jun 11, 2026
Tumor-resident T cells and dendritic cells form an in situ archetype during immunotherapy response in melanoma.

Pageof 6

Frequent Collaborators

7 joint publications

Georgina V Long

6 joint publications

Paolo A Ascierto

5 joint publications

Ian D Davis

5 joint publications

Eva Muñoz-Couselo